Генетика легочной гипертензии

Брегель Людмила Владимировна, Белозеров Юрий Михайлович, Новиков Петр Васильевич et al. · Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) · 2014

Recent clinical and experimental studies data are considering relating to the genetic causes of pulmonary arterial hypertension (PAH). The genetic abnormalities were first identified in association with the idiopathic and familial form of PAH, and some cases of secondary PAH following congenital heart defects (CHD). Genetic polymorphism of BMPR2, SMADs, ALK1/ENG were described as a reason of TGF-β-cell signaling disturbances. These genetic abnormalities were found in 6—18,2% of the patients with PAH owing to CHD. There are 70-80% heterozygote carriers of BMPR2-gene mutation among the relatives of familial PAH patients. The effects of the abnormal BMPR2 signaling pathway develop with the participation of ALK-receptors and transcriptional SMAD-proteins. Then BMPR2 и BMPR1B dysfunction culminate in an expressed smooth cells proliferative response that occludes the pulmonary arterial lumen and increases the apoptosis of the endoteliocytes in the small pulmonary arteries.

Cited by 0 works.

Authors